Parathyroid disease, most commonly primary hyperparathyroidism, occurs when one or more of the four parathyroid glands produces excessive parathyroid hormone (PTH), leading to elevated blood calcium levels. This can cause kidney stones, bone loss, fatigue, depression and muscle weakness. Parathyroidectomy is the definitive cure, with success rates exceeding 95 percent in experienced hands.
The parathyroid glands are four tiny glands, each roughly the size of a grain of rice, situated behind the thyroid gland in the neck. Despite their name, they have no functional relationship to the thyroid: they are entirely separate endocrine organs that regulate calcium balance by producing parathyroid hormone (PTH).
Hyperparathyroidism is classified into three types:
The classic teaching summarises hyperparathyroidism symptoms as "bones, stones, abdominal groans and psychic moans." Many patients present with vague, non-specific symptoms that have been present for years before diagnosis:
Many patients with primary hyperparathyroidism are initially asymptomatic, with the condition discovered incidentally on routine blood tests showing elevated calcium. However, studies show that even these "asymptomatic" patients often have subtle symptoms that improve significantly after surgery.
At Central Sydney ENT, parathyroid disease is diagnosed through:
Blood tests: The hallmark of primary hyperparathyroidism is elevated serum calcium with an inappropriately elevated or non-suppressed PTH level. Additional tests include phosphate (typically low), vitamin D, renal function and 24-hour urine calcium to exclude familial hypocalciuric hypercalcaemia (a benign condition that mimics hyperparathyroidism).
Sestamibi-SPECT/CT scan: A nuclear medicine scan using technetium-99m sestamibi, which is preferentially taken up by overactive parathyroid tissue. Combined with CT (SPECT/CT), this provides precise anatomical localisation of the abnormal gland, enabling minimally invasive surgery.
Neck ultrasound: High-resolution ultrasound can identify enlarged parathyroid glands and is used in combination with sestamibi scanning for concordant localisation, increasing accuracy.
4D CT scan: In cases where sestamibi and ultrasound are discordant or non-localising, 4D CT provides detailed perfusion imaging that can identify abnormal parathyroid glands with high sensitivity.
DEXA scan: Bone density assessment to determine whether hyperparathyroidism has caused osteoporosis, which is one of the established indications for surgery.
Surgery is the only curative treatment for primary hyperparathyroidism and is recommended for all symptomatic patients and for asymptomatic patients who meet established surgical criteria (calcium level more than 0.25 mmol/L above normal, osteoporosis, kidney stones, reduced kidney function, or age under 50).
When pre-operative imaging has localised a single abnormal gland, minimally invasive focused parathyroidectomy is performed through a small 2-3 centimetre incision. The abnormal gland is removed and intraoperative PTH measurement confirms successful cure (PTH should drop by more than 50 percent within 10-15 minutes of gland removal). Cure rates exceed 95 percent.
Our head and neck surgeons: including Dr Alexander Zhang and Dr Rahuram Sivasubramaniam: perform parathyroid surgery with intraoperative PTH monitoring across Central Sydney ENT locations.
For patients who are not surgical candidates, medical management may include adequate hydration, cinacalcet (a calcimimetic that reduces PTH secretion and calcium levels), bisphosphonates for bone protection, and monitoring of calcium, kidney function and bone density. However, medical therapy does not cure the disease and requires lifelong treatment.
You should seek a referral to an ENT or head and neck specialist if:
Parathyroid disease is closely linked to several other conditions treated at Central Sydney ENT:
Ask your GP or endocrinologist for a referral to Central Sydney ENT, or call our reception team directly.
Call (02) 9747 3199